As of 2026-09-25, the Relative Valuation of Inhibrx Inc (INBX) is (201.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 100.40 USD, the upside of Inhibrx Inc based on Relative Valuation is -300.5%.
The range of the Relative Valuation is (181.79) - (236.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 25.1x | 22.2x |
| Forward P/E multiples | 15.9x - 25.2x | 20.6x |
| Fair Price | (181.79) - (236.42) | (201.34) |
| Upside | -281.1% - -335.5% | -300.5% |
| Date | P/E |
| 2026-09-24 | -10.66 |
| 2026-09-23 | -10.65 |
| 2026-09-22 | -11.75 |
| 2026-09-21 | -11.89 |
| 2026-09-18 | -11.61 |
| 2026-09-17 | -11.12 |
| 2026-09-16 | -10.80 |
| 2026-09-15 | -11.21 |
| 2026-09-14 | -11.73 |
| 2026-09-11 | -11.60 |
| 2026-09-10 | -11.83 |
| 2026-09-09 | -11.98 |
| 2026-09-08 | -12.14 |
| 2026-09-04 | -12.86 |
| 2026-09-03 | -12.98 |
| 2026-09-02 | -13.27 |
| 2026-09-01 | -13.23 |
| 2026-08-31 | -13.45 |
| 2026-08-28 | -13.10 |
| 2026-08-27 | -13.16 |
| 2026-08-26 | -13.31 |
| 2026-08-25 | -13.03 |
| 2026-08-24 | -11.14 |
| 2026-08-21 | -11.00 |
| 2026-08-20 | -10.53 |
| 2026-08-19 | -10.77 |
| 2026-08-18 | -10.05 |
| 2026-08-17 | -9.77 |
| 2026-08-14 | -9.38 |
| 2026-08-13 | -10.30 |
| 2026-08-12 | -10.44 |
| 2026-08-11 | -9.81 |
| 2026-08-10 | -9.89 |
| 2026-08-07 | -9.41 |
| 2026-08-06 | -9.11 |
| 2026-08-05 | -8.91 |
| 2026-08-04 | -8.87 |
| 2026-08-03 | -8.78 |
| 2026-07-31 | -8.71 |
| 2026-07-30 | -9.00 |
| 2026-07-29 | -8.41 |
| 2026-07-28 | -8.46 |
| 2026-07-27 | -8.75 |
| 2026-07-24 | -8.66 |
| 2026-07-23 | -9.02 |
| 2026-07-22 | -9.12 |
| 2026-07-21 | -9.30 |
| 2026-07-20 | -8.93 |
| 2026-07-17 | -9.28 |
| 2026-07-16 | -9.46 |